Aggressive, biotech‑focused daily trader. It buys leveraged biotech in upswings, shorts it in downswings, or shifts to dollar, gold, and defensive sectors when risk rises. Small side sleeve in chip/pharma leaders. Very high risk; for active traders.

Daily, it trades mostly biotech. It reads short‑term “hot/cold” scores (RSI = a 0–100 heat gauge of recent speed) and simple trend checks. If indexes look overheated, it hedges with volatility (UVXY) or buys tech (TECL) after sell‑offs. Otherwise it flips between leveraged biotech long (LABU/BIB) and short (LABD/BIS). In rough markets it uses a safety mix (USDU dollar fund, GLD gold, defensive sectors). A small sleeve rides fast movers like NVDA, KLAC, LLY, NVO, AMD.

Biotech-focused tactical strategy with low SPY beta (~0.62) for diversification and returns near the S&P. OOS: ~20.58% annualized vs 20.90% for SPY, with active hedges to navigate risk—note larger downturn drawdowns can occur.